Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.
2.

The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study.

Heun R, Ahokas A, Boyer P, Giménez-Montesinos N, Pontes-Soares F, Olivier V; Agomelatine Study Group.

J Clin Psychiatry. 2013 Jun;74(6):587-94. doi: 10.4088/JCP.12m08250.

PMID:
23842010
3.
4.

Metabolic imbalance in affective disorders.

Ladea M, Barbu CM, Rosu DP.

J Med Life. 2013 Mar 15;6(1):45-9. Epub 2013 Mar 25.

5.

Nutrition and depression at the forefront of progress.

Popa TA, Ladea M.

J Med Life. 2012 Dec 15;5(4):414-9. Epub 2012 Dec 25.

6.

A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder.

Weiser M, Gershon AA, Rubinstein K, Petcu C, Ladea M, Sima D, Podea D, Keefe RS, Davis JM.

Schizophr Res. 2012 Jun;138(1):35-8. doi: 10.1016/j.schres.2012.02.014. Epub 2012 Apr 4.

PMID:
22483162
7.

Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.

Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z.

Arch Gen Psychiatry. 2011 Mar;68(3):241-51. doi: 10.1001/archgenpsychiatry.2011.12.

8.

Markers of vulnerability in schizophrenia.

Ladea M, Prelipceanu D.

J Med Life. 2009 Apr-Jun;2(2):155-64. Review.

9.

Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study.

Benecke H, Pérez-Garrigues H, Bin Sidek D, Uloziene I, D K, Sondag E, Theeuwes A; OSVaLD investigators.

Int Tinnitus J. 2010;16(1):14-24.

PMID:
21609908

Supplemental Content

Loading ...
Support Center